<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02269449</url>
  </required_header>
  <id_info>
    <org_study_id>TRI20140920</org_study_id>
    <nct_id>NCT02269449</nct_id>
  </id_info>
  <brief_title>Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial</brief_title>
  <acronym>RAPandBEAT</acronym>
  <official_title>RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NPO International TRI Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Cardiovascular Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NPO International TRI Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to demonstrate the safety and efficacy of the new 6Fr sheath
      (Glidesheath slender; Terumo, Tokyo,Japan ; GSS) compared with the contemporary 5Fr sheath
      (Hydrophilic coating sheath from Terumo; Tokyo, Japan (standard of care ; SOC).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radial artery occlusion</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Local bleeding from puncture site</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure success rate</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access site complication</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial spasm during the index procedure</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Procedure Time</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Amount of Contrast Dye</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Radiation Doses</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device failure for the assigned sheath introducer</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1900</enrollment>
  <condition>Percutaneous Coronary Intervention</condition>
  <arm_group>
    <arm_group_label>6Fr Glidesheath Slender sheath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TRI will be performed using a new 6Fr sheath (Glidesheath slender: GSS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5Fr contemporary sheath</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TRI will be performed using a contemporary safety of 5Fr sheath.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hemostasis with TR band</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemostasis is achieved by randomization of using TR band (TERUMO) Patent hemostasis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Any hemostasis procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hemostasis is achieved by randomization of any hemostasis of each hospital's routine procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>6Fr Glidesheath Slender sheath</intervention_name>
    <description>6Fr sheath (Glidesheath slender: GSS), which is characterized with the same inner lumen diameter with contemporary 6Fr sheath as well as the sheath outer diameter similar with contemporary 5Fr sheath.</description>
    <arm_group_label>6Fr Glidesheath Slender sheath</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>5Fr sheath</intervention_name>
    <description>5Fr Hydrophilic coating sheath from Terumo.</description>
    <arm_group_label>5Fr contemporary sheath</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemostasis with TR band</intervention_name>
    <description>Hemostasis is achieved using TR band (TERUMO) Patent hemostasis.</description>
    <arm_group_label>Hemostasis with TR band</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Any hemostasis procedure</intervention_name>
    <description>Hemostasis is achieved by any hemostasis of each hospital's routine procedure.</description>
    <arm_group_label>Any hemostasis procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is able to verbally acknowledge an understanding of the associated risks,
             benefits and treatment alternatives and he or his legally authorized representative
             provides written informed consent prior to the randomization, as approved by the
             appropriate IRB.

          -  Patient who is expected to diagnose by coronary artery angiography or followed by PCI.

          -  Patient must agree to undergo all protocol-required follow-up examinations.

          -  Patient who can accept radial access.

        Exclusion Criteria:

          -  Patient has other medical illness (e.g., cancer or congestive heart failure) that may
             cause non-compliance with the protocol, confound the data interpretation or is
             associated with a limited life expectancy (i.e., less than one year).

          -  Hemodialysis patient

          -  STEMI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2014</study_first_submitted>
  <study_first_submitted_qc>October 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>October 16, 2014</last_update_submitted>
  <last_update_submitted_qc>October 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transradial intervention</keyword>
  <keyword>radial artery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

